Pluristem Therapeutics Inc (PSTI)

[Spideyboy]

Perfect, topic I wanted to broach next.

Something I wanted to also note as matter of interest with regards contacting PSTI.

The reason why I am aware of the information about R18 and the importance of IL-6 with regards R18 mechanism of action vis-a-vis CBLI's Entolimod, is thanks to PSTI's VP Karine Klainhaus.

Around this past Christmas period I wrote to Karine asking for the additional R18 NHP ARS data that was presented at the ASH conference. She politely wrote back to me within the day to say that she would go find the poster for me.

She then wrote back a few days later with the poster and data provided, from which it can be deduced that the IL-6 and quite possibly also IL-8 are the key additional cytokines over CBLI's Entolimod that support the Platelet (IL-6) and RBC (IL-8).

While I don't know how to share the presentation with you as this is a PDF file that I can't upload here, I can point you to the Entolimod research and Mechanism of Action. These have already bee posted in my prior post but for convenience I provide again:
Research: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569586/#!po=33.2278
MoA (from the same research paper): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569586/figure/pone.0135388.g006/

So quite contrary to you Scott999 with you inability to communicate with Karine:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136923256
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136409328
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136920957

Karine was polite and provided as requested to a retail investor as myself despite the holiday season. With no need to follow-up communication on my behalf.

Thus from this experience, I would find it without a problem to contact Karine.

Perhaps, yourself (using clownz as an example just now), Blue and Eich need to revise your way of communicating in general.